CVRx, Inc. (CVRX) stock
CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3091% below fair value
$0.60−0.01 (-1.15%)
Close on Nov 18, 2026Market cap $16.09MP/E –Yield –
CVRx net income
Net income is the profit left for shareholders after every expense, interest and tax.
CVRx's net income for the twelve months ending Jun 30, 2026 was -$51.97M. For fiscal 2025 it was -$53.31M. The highest annual figure on record is -$14.11M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$53.31M | – |
| FY2024 | Dec 31, 2024 | -$59.97M | – |
| FY2023 | Dec 31, 2023 | -$41.20M | – |
| FY2022 | Dec 31, 2022 | -$41.43M | – |
| FY2021 | Dec 31, 2021 | -$43.08M | – |
| FY2020 | Dec 31, 2020 | -$14.11M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$14.04M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.12M | – |
| Q4 FY2025 | Dec 31, 2025 | -$11.93M | – |
| Q3 FY2025 | Sep 30, 2025 | -$12.87M | – |
| Q2 FY2025 | Jun 30, 2025 | -$14.74M | – |
| Q1 FY2025 | Mar 31, 2025 | -$13.77M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.65M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.10M | – |
| Q2 FY2024 | Jun 30, 2024 | -$14.03M | – |
| Q1 FY2024 | Mar 31, 2024 | -$22.19M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.16M | – |
| Q3 FY2023 | Sep 30, 2023 | -$9.01M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.65M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.37M | – |
| Q4 FY2022 | Dec 31, 2022 | -$10.54M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.83M | – |
| Q2 FY2022 | Jun 30, 2022 | -$11.07M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.99M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.57M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.13M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.75M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.63M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.40M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.23M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.67M | – |
See a number that looks wrong?